Materials and Methods: Synthesis
All chemicals were obtained from commercial suppliers and used without further purification. Technologies 1200 Series Instrument with a G1316A variable wavelength detector set at λ= 210 nm, 1200 Series ELSD, 6110 quadrupole ESI-MS, using an Agilent Eclipse XDB-Phenyl column (3 × 100mm, 3.5 μm particle size, flow rate 1 mL/min, the mobile phases 0.05% formic acid in water and 0.05% formic acid in acetonitrile). Compound purification was performed using an Agilent 1260 Infinity Preparative HPLC with a G1365D multiple wavelength detector set at λ= 210 nm and an Agilent Eclipse XDB-Phenyl column 21.2 x 100mm, 5 μm particle 12 size. High resolution mass spectrometry (HRMS) was performed on a Bruker Micro TOF mass spectrometer using (+)-ESI calibrated to sodium formate. Final compound purity of ≥ 95% was confirmed by LCMS analysis using both ELSD and UV (210 nm) detection.
All
Resin-bound Fmoc-L-Thr-OAllyl 3 (0.62 mmol/g) was prepared as previously described. [3] General method for Peptide Coupling (Compound 8 in Scheme S1 as example): Fmoc protected resin 3 (100 mg, loading 0.62 mmol/g) was treated with a solution of 30% piperidine in DMF (2 mL) and shaken at rt for 15 min. The resin was drained and washed with DMF (× 3), MeOH (× 3) and DCM (× 3). The deprotection step was repeated. A solution of the corresponding amino acid (0.14 mmol, 2 eq.), DMF (0.29 mL), HCTU (0.5 M in DMF, 0.29 mL, 0.14 mmol, 2 eq.) and DIPEA (50 µL, 0.14 mmol, 4 eq.) was combined. After 1 min, the mixture was added to the resin. The resin was shaken for 30 min and then washed with DMF (× 3), MeOH (× 3) and DCM (× 3). The coupling step was repeated. An analytical sample was cleaved with TFA/Et3SiH/H2O (95:1:4) followed by LCMS analysis to confirm coupling with corresponding amino acid.
The corresponding O-Allyl / N-Alloc protected heptapeptide DHP-resin 4 was washed with dry DCM (× 3). A solution of Pd(PPh3)4 (0.25 equiv) in dry DCM (2 mL) was added to the resin followed by phenylsilane (24 equiv). The resin was carefully shaken and the excess pressure was released several times until no increase in pressure was observed. The resin was then shaken at rt for 2 h, drained and washed with 0.5% DIPEA in DCM (× 5), 0.5% w/v sodium diethyl dithiocarbamate trihydrate in DMF (× 8), MeOH (× 3) and DCM (× 3) and dried under vacuum. An analytical sample was cleaved using TFA/Et3SiH/H2O (95:1:4) followed by LCMS analysis to confirm complete bis-deprotection.
The O-Allyl / N-Alloc deprotected resin 5 was washed with DCM (× 3) and DMF (× 3) and then treated with a solution of DPPA (5.0 equiv) and DIPEA (10 equiv) in DMF (2 mL). The resin was shaken at room temperature overnight, drained and washed with DMF (× 3), MeOH (× 3) and DCM (× 3). An analytical sample was cleaved using TFA/Et3SiH/H2O (95:1:4) followed by LCMS analysis to confirm complete cyclization. Resin 6 was treated with piperidine/DMF as described above to remove the P4 Fmoc group. 
